Medication info
Coscar 25 mg (Losartan Potassium)

Coscar 25 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›25mg / 1 tablet
Manufacturer / importer
SK Chemicals Co., Ltd.
Appearance
White, round film-coated tablet
Packaging
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Approval status
Active

MFDS item code 202103090 · Approved 2021.04.13 · Insurance code 644704880

Summary

Main use
Treatment of hypertension and kidney disease in patients with type 2 diabetes mellitus and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to up to 100 mg once daily. 2) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. 4) Patients with reduced effective intravascular volume For a small number of patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended. (See the 'Precautions for Use' section.) 5) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).
Child dose
6) Pediatric and adolescent patients aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily. (3) This medicine is not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
SK Chemicals Co., Ltd.

Efficacy & effects

Treatment of hypertension and kidney disease in patients with type 2 diabetes mellitus and hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to control blood pressure in patients with hypertension. Additionally, it helps prevent and treat kidney disease in patients who have both hypertension and type 2 diabetes. Therefore, it is effective for blood pressure management as well as improving kidney health.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to up to 100 mg once daily. 2) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. 4) Patients with reduced effective intravascular volume For a small number of patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended. (See the 'Precautions for Use' section.) 5) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. 7) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to up to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).

Child dose

6) Pediatric and adolescent patients aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily. (3) This medicine is not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, with increased risk of impaired lung development, skeletal deformities, hypotension, and renal failure in newborns. Upon confirmation of pregnancy, this medication should be discontinued immediately, and women who may become pregnant should avoid taking this medication. Patients who have allergic reactions to this medication, severe liver dysfunction, or hereditary angioedema should avoid taking it. Furthermore, patients with hyperkalemia or severely impaired kidney function, as well as those with certain heart valve diseases, should use caution when taking this medication. As this medication lowers blood pressure, symptoms of hypotension may occur, including dizziness or fainting. Potassium levels in the blood may increase; hence, it should not be taken with potassium supplements or medications containing potassium, and regular blood tests should be conducted. Since liver dysfunction or deterioration of kidney function may occur, patients should consult their doctor immediately if any unusual symptoms appear. Caution should be taken when driving or operating machinery as dizziness or drowsiness may occur during treatment. Children, especially those under 6 years of age or with significantly impaired kidney function, should not take this medication. In case of overdose, hypotension and bradycardia may occur; immediate medical attention should be sought. This medication is not recommended for breastfeeding women, and if it must be taken, breastfeeding should be stopped. When storing the medication, it should be kept in a tightly sealed container, out of reach of children, and not transferred to other containers.

Side effects

  • Decreased skull formation
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • lumbar pain
  • limb pain
  • dizziness
  • congestion
Show 136 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory impairment
  • decreased libido
  • cognitive impairment
  • migraine
  • neuroexcitability
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reactions
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • eye pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • malaise
  • elevated creatine kinase
  • rhabdomyolysis
  • dry cough
  • erythromelalgia
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased creatinine
  • increased BUN
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic contractions
  • atrial fibrillation
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it should be kept at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

White, round film-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.